Organoids, 3D cultures derived either from PCa cell lines or patient tumours that maintain the genetic and phenotypic characteristics of the original tumour, may offer a promising platform for drug screening and understanding IL-8/CXCR1/2 tumour-intrinsic and TME biology in a controlled environment [55]. The gene discussed is CXCL8; the disease is posterior cortical atrophy.